History video
The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Nieder-Ingelheim. Watch the video here to learn more.
Search
This ensures food security for one year
In Ghana, we are helping smallholder farmers overcome hardship caused by the pandemic. Click here to read about this story and find out more.
A Unique Bond: by my side
Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life. Click here to watch the video.
Companion Animals
Boehringer Ingelheim Animal Health helps provide longer, healthier and happier lives for companion animals. Click here to learn and find out more.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
COVID-19 France Production of hydroalcoholic-gel
We have launched production of our first hydro-alcoholic solution for internal use to help battle COVID-19. Click here to find out and learn more.
Thelaziosis dog eyeworms
Most pet owners probably do not associate the scientific name “thelaziosis” to eyeworm infestations experienced by their dogs. Click here to learn more.
best-practice-innovative-Corporate-Citizenship-survey
Boehringer Ingelheim is named best practice example for innovative Corporate Citizenship in Germany by CC-survey. Click here to learn more about this.
Patient Voices...Ian's Story
Watch the video to find out more about how Ian manages AF in his day to day life. Ian discusses the importance of educating yourself and more.
About Us
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to learn and find out more about us.
A Unique Bond: human and animal health
At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets. Learn more here.
Angels Initiative in South Africa
Dr Stacey Rossouw explains how the Angels initiative is making a difference in South Africa and optimising stroke care. Click here to learn more.
Accessibility Statement
Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
Say no to the uninvited guests
Boehringer Ingelheim aims to raise awareness of the issues & risks that parasites can have on cats. Click here to find out more information.
A beginner’s guide to fighting off cat parasites
Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats. Click here to read and find out more information.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
Corporate Profile
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. Learn more about our company here.
It’s Your Heart. Protect It. The Podcast.
In season 2, we hear from a range of experts to explore further how the interconnected systems call for collaboration and approach to care. Learn more.
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
Animal Health: Our Responsibility
The importance of sustainability and of the interconnection between human, animal and environmental health is firmly anchored in our philosophy.
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting the Boehringer Ingelheim site.
Transboundary and emerging diseases
We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.